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Abstract
4-Methylimidazole (4-MI) is formed as a result of the Maillard reaction process, and therefore is found in many
foods and beverages. It is also found in soft drinks (i.e., cola) as a by-product in the production of some caramel
colors. NTP bioassays revealed clear evidence of lung carcinogenicity of 4-MI in male and female mice, but not in
rats and then IARC classified 4-MI as group 2B carcinogen. Genotoxicity studies with 4-MI were negative in the
Ames tests and in the erythrocyte micronucleus tests with mice or rats. US California EPA (CEPA) evaluated the
testing has not been adequately comprehensive to rule out a genotoxic mode of action; as target tissue of the
carcinogenicity of 4-MI was lung, the lung should be used as a source tissue for in vitro metabolic activation
system. Thus, CEPA defined the No Significant Risk Level (NSRL) for 10−5 lifetime risk level of cancer by 4-MI as
29 μg/day based on the non-threshold approach. As higher levels of 4-MI than the NSRL were identified in some
kinds of cola, health concerns of 4-MI were drawn the attention. On the other hand, other regulatory bodies (e.g.,
European Food Safety Authority, EFSA) showed no concerns of 4-MI from the use of caramel colors in food. EFSA
evaluated 4-MI is not genotoxic, so, non-observed adverse effect level of 4-MI was considered to be 80 mg/kg/day.
In this paper, genotoxic assessments of 4-MI in different regulatory bodies are presented and the risk evaluation of
4-MI is discussed based on new genotoxicity data.
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Background
4-Methylimidazole (4-MI) will be present or subject to
unavoidable formation during cooking in certain foods
and beverages, including coffee, carbonated beverages,
beer, soy sauce and crackers, as a product of Maillard re-
action. Thus, some soft drinks which use caramel color-
ing (class III and IV) will contain 4-MI [1]. An increased
incidence of lung tumors was reported in mice, but not
rats, exposed to levels of 4-MI in their diet that far exceed
(more than 10,000 times) human dietary intake [2, 3].
International Agency for Research on Cancer (IARC) clas-
sified 4-MI as group 2B carcinogen based on the animal
data [1, 4]. 4-MI does not induce mutation in Salmonella
and does not induce micronuclei in rodent peripheral
erythrocytes or bone marrow cells [2, 5]. Different evalua-
tions have been made on the genotoxicity of 4-MI, i.e.,
sufficient evidence for drawing clear negative conclusion
or not, among regulatory bodies. Clarification of factor
of the difference is important for regulatory decisions
with transparency and fairness in chemical management
and control.
4-Methylimidazole (4-MI)
4-MI (CAS RN 822-36-6) is light yellow crystalline solid.
It is used as a chemical intermediate, raw material or
component in the manufacture of pharmaceuticals,
photographic chemicals, dyes and pigments, agricultural
chemicals and rubber. 4-MI is formed as a result of the
interaction of ammonia with reducing sugars [1]. There-
fore, it will be found as byproduct in some foods and
beverages during the normal cooking process associated
with heat and browning. 4-MI also forms as a trace im-
purity during the manufacturing of class III (ammonia
caramel) and class IV (sulphite-ammonia caramel) cara-
mel coloring [3]. Thus, 4-MI was identified in some
types of soft drinks [6, 7].* Correspondence: morita-tk@nihs.go.jp1Division of Risk Assessment, National Institute of Health Sciences, 1-18-1
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Carcinogenicity of 4-MI
In 2007, US National Toxicology Program (NTP) issued
a report of results from toxicology and carcinogenesis
studies of 4-MI in rats and mice [2]. A 2-year study in
rats was inconclusive regarding carcinogenicity, but a
2-year mouse study showed an increased incidence of
certain lung tumors (alveolar/bronchiolar neoplasms).
Based on the NTP bioassay data and other relevant
data, IARC assigned 4-MI as possibly carcinogenic to
humans (group 2B) [1].
Genotoxicity of 4-MI
Genotoxicity data on 4-MI is summarized in Table 1. 4-
MI was negative in bacterial reverse mutation assay with
Salmonella typhimurium TA97, TA98, TA100, TA1535,
TA1537 or TA1538 up to 10,000 μg/plate in the presence
or absence of S9 from rat or hamster liver, or Escherichia
coli WP2 uvrA. 4-MI did not induce micronucleated
erythrocytes in male or female mice treated by feeding up
to 10,000 ppm (3200 or 1900 mg/kg/day, respectively) for
92 days in the peripheral blood micronucleus test. 4-MI
was also evaluated in bone marrow micronucleus test in
male rats or mice treated by intraperitoneal injection
(three times once a day) up to 100 or 200 mg/kg, respect-
ively. No increase in micronuclei was observed in the rats
and mice (Table 1) [1, 5].
Regulatory perspectives of genotoxic concern
of 4-MI
NTP
It is unlikely that an alkylating intermediate is involved
in mouse lung carcinogenesis in view of the genotoxicity
study findings that 4-MI is not mutagenic in S. typhimur-
ium and does not induce micronuclei in mouse peripheral
blood erythrocytes or rat and mouse bone marrow cells.
The mechanism of action of 4-MI in mouse lung tumori-
genesis is not clear [8].
IARC
4-MI induced neither mutations nor chromosomal aber-
rations in vitro or in vivo. The mechanism of action of
4-MI in mouse lung tumorigenesis is not clear [1].
California Environmental Protection Agency (CEPA)
No Significant Risk Level (NSRL) for 4-MI has been calcu-
lated to be 29 μg/day under the regulation of Proposition
65. Proposition 65 (the Safe Drinking Water and Toxic
Enforcement Act of 1986) is a California law which in-
tends to protect California citizens and the State’s drinking
water sources from chemicals known to cause cancer,
birth defects or other reproductive harm, and to inform
citizens about exposures to such chemicals [9]. The NSRL
is defined as the daily intake level posing a 10−5 lifetime
risk of cancer. Neither the mechanism(s) nor mode(s) of
action of carcinogenicity of 4-MI is known. Though the
available literature has provided little evidence for the gen-
otoxicity of 4-MI, the testing has not been adequately
comprehensive to rule out a genotoxic mode of action
(MOA), particularly in the lung. Since the lung is a pri-
mary target tissue in mice, it may be more appropriate to
use a metabolic activation system derived from pulmonary
tissue. In addition, the implications of the negative results
in bone marrow and peripheral blood erythrocytes are un-
clear. There is not sufficient evidence to justify departing
from the default assumption. Thus, CEPA has adopted in
its assessment that the carcinogenic effect of 4-MI is not a
threshold mechanism [5].
European Food Safety Authority (EFSA)
EFSA considered that the carcinogenic effect of 4-MI
seen in mice in this study was thresholded, based on the
lack of genotoxicity of 4-MI, also noting that alveolar/
bronchiolar neoplasms occur spontaneously at high inci-
dence in B6C3F1 mice. EFSA concluded therefore that
the intermediate dose of 625 mg 4-MI/kg diet, equiva-
lent to 80 mg 4-MI/kg bw/day could be considered to be
Table 1 Genotoxicity data on 4-methylimidazole
Test System and conditions Dose Result Reference
Bacterial reverse
mutation test
Salmonella typhimurium TA97, TA98, TA100, TA1535, TA1537
and TA1538. With and without S9 from rat or hamster liver.
100 – 10,000 μg/plate Negative [1, 5]
Bacterial reverse
mutation test
Escherihia coli WP2 uvrA. With and without S9. 9.77 – 5000 μg/plate Negative [5]
Bacterial reverse
mutation test
Salmonella typhimurium TA98, TA100, TA1535, TA1537
and TA102. With and without S9 from rat liver or lung,
or mouse liver or lung.
5 – 5000 μg/plate Negative [14]
SAR analysis Three softwares including Osiris, ToxTree and DEREK. Not applicable Negative [13]
Micronucreus assay Male and female mouse peripheral blood. Diet for 92 days. 625 – 10,000 ppm (up to 3200 mg/kg/day
for male, 1900 mg/kg/day for female)
Negative [1, 5]
Micronucreus assay Male mouse bone marrow. Three intraperitoneal injections. 25 – 200 mg/kg Negative [1, 5]
Micronucreus assay Male rat bone marrow. Three intraperitoneal injections. 25 – 100 mg/kg Negative [1, 5]
SAR structure-activity relationship
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a non-observed adverse effect level (NOAEL) in this
study [10].
US Food and Drug Administration (FDA)
NTP carcinogenicity studies were conducted in rodents
at levels of 4-MI that far exceed current estimates of
human exposure to 4-MI from the consumption of class
III and class IV caramel coloring in food products such
as colas. In 2012, EFSA re-evaluated the consumer ex-
posure to 4-MI from the use of caramel colors, and
reaffirmed its 2011 conclusion [11]. EFSA also noted
that 4-MI does not appear to cause DNA mutations
(genotoxicity) and that the type of tumors observed in
the mice from the NTP study can occur spontaneously
in these animals. For these reasons, EFSA concluded that
they had no concerns about Europeans being exposed to
4-MI from the use of caramel coloring in food [2, 10].
German Federal Institute for Risk Assessment (BfR)
BfR checked the data on 4-MI and the opinion of EFSA.
EFSA stated in its opinion that the carcinogenic effect of
4-MI in mice a threshold value can be accepted since it
with 4-MI no genotoxic effects were observed. EFSA
also pointed out that with 4-MI tumors observed in
mice a comparatively high spontaneous rate. BfR agreed
with EFSA’s opinion that the maximum quantities for
4-MI in caramel class III or IV according to the current
state of science are completely harmless [12].
Different regulatory perspectives and new
genotoxicity data on 4-MI
The issue underlying regulatory perspectives of health
concern of 4-MI is evaluation of genotoxic MOA in the
mouse carcinogenicity of 4-MI. Though the mechanism
of action of 4-MI in mouse lung tumorigenesis is not
clear, regulatory bodies except for CEPA considered the
carcinogenicity is not genotoxic MOA based on the
existing data [3, 10, 11]. On the other hand, CEPA could
not rule out possible genotoxic MOA in the target organ
(i.e., lung); therefore, CEPA employed non-threshold
mechanism on 4-MI carcinogenicity as default assump-
tion [5]. Recently, new genotoxicity data on 4-MI has
been published (Table 1) [13, 14]. Analysis with three
structure-activity relationship software including Osiris,
ToxTree and DEREK revealed that 4-MI is not geno-
toxic and carcinogenic [13]. In addition, 4-MI did not
increase revertant colonies at doses tested up to
5000 μg/plate in Salmonella typhimurium strains TA98,
TA100, TA1535, TA1537 and TA102 both in the absence
and presence of exogenous metabolism, regardless of
whether metabolic activity was provided by S9 from in-
duced rat liver or lung or mouse liver or lung [14].
These new data and other existing genotoxicity data in-
dicate that 4-MI is a non-genotoxic substance and the
mechanism of induction of lung tumors in mice treated
by 4-MI is highly unlikely due to genotoxicity. Therefore,
application of the threshold mechanism to the 4-MI
carcinogenicity is reasonable.
Risk evaluation of 4-MI in caramel colors, foods
or beverages
As 4-MI is not genotoxic, estimated tolerable daily in-
take will be calculated 0.8 mg/kg/day (48 mg in terms of
60 kg body weight per person), based on the NOAEL of
80 mg/kg/day evaluated by EFSA (safety factor 100) [10].
When 500 mL of a certain type of soft drink which con-
tains 0.7 mg 4-MI/kg will be drunken, a maximum in-
take of 4-MI will be 0.35 mg/person (Fig. 1b); this
exposure level does not cause any risk of 4-MI contained
in beverages which use caramel colors class III or IV.
Fig. 1 Concentration of 4-methylimidazole in caramel colors class III and IV (a), or in some beverages or foods (b). Each caramel color or bever-
age/food which contains maximum level of 4-MI was selected among several samples. Class III-1 to III-5 and IV-1 to IV-4 mean different samples
among class III or IV caramel color products. Data were modified from IARC Monographs 101 [1]. *: Foods cooked in soya sauce
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Low level of exposure of 4-MI is the reason that EFSA
states no concerns of health effect by 4-MI derived from
caramel colors. EFSA considered it would be prudent to
reduce 4-MI level as much as technology feasible [10].
Therefore, the maximum level of the constituent 4-MI,
found in caramel class III and class IV only, was re-
stricted to <250 mg/kg caramel on a color intensity basis
in the year 2012 [15]. The specification was defined as
much as technologically feasible (Fig. 1a) [15]. Exposure
level of 4-MI from soft drink (e.g., cola) is not high due
to low concentration and small amount of cola intake.
The mechanism by which 4-MI induces lung tumors in
mice but not rats is unknown. The hypothesis that 4-MI
and styrene induce lung tumors by the same MOA (i.e.,
CYP2F2 metabolic activation) has not been supported
by recent investigations [16]. Further investigation on
the mechanism of the mouse carcinogenicity will help
the risk assessment of 4-MI.
Conclusion
Evaluation of involvement of genotoxic mechanism in
chemical carcinogenesis is important for the regulatory
decisions in the chemical control and management. Dif-
ferent approach will be adopted based on the evaluation,
i.e., threshold or non-threshold approach. Recent geno-
toxicity data supports that 4-MI is non-genotoxic car-
cinogen. Therefore, threshold level can be applied.
There is no health concern on 4-MI from soft drinks
which use certain types of caramel colors. Risk evalu-
ation of 4-MI from other foods which contain higher
level of 4-MI might be needed.
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